Kala Bio: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Kala Bio (NASDAQ:KALA) reported Q3 earnings with an EPS of $-3.41, missing estimates by 58.6% compared to the expected $-2.15. Revenue also decreased by $420 thousand from the same period last year. Following last quarter's earnings miss, KALA's share price dropped by 1.6% the next day.
November 13, 2023 | 1:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Kala Bio reported a significant earnings miss and a year-over-year revenue decline in Q3, which may negatively impact investor sentiment and the stock price in the short term.
Kala Bio's earnings miss by a wide margin and the decrease in revenue compared to the previous year are likely to be viewed negatively by investors. Historical data from the last quarter shows a stock price decline following an earnings miss, suggesting a similar reaction could occur this quarter.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100